Very-Low-Density Lipoprotein–Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III

BACKGROUND: Routine apolipoprotein (apo) measurements for cardiovascular disease (CVD) are restricted to apoA-I and apoB. Here, the authors measured an unprecedented range of apolipoproteins in a prospective, population-based study and relate their plasma levels to risk of CVD. OBJECTIVES: This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Pechlaner, Raimund, Tsimikas, Sotirios, Yin, Xiaoke, Willeit, Peter, Baig, Ferheen, Santer, Peter, Oberhollenzer, Friedrich, Egger, Georg, Witztum, Joseph L., Alexander, Veronica J., Willeit, Johann, Kiechl, Stefan, Mayr, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Biomedical 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314136/
https://www.ncbi.nlm.nih.gov/pubmed/28209220
http://dx.doi.org/10.1016/j.jacc.2016.11.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314136/
https://www.ncbi.nlm.nih.gov/pubmed/28209220
http://dx.doi.org/10.1016/j.jacc.2016.11.065

Ejemplares similares